Autologous Bone Marrow-Derived Stem Cells for Chronic Wounds of the Lower Extremity: A Retrospective Study
- 0 Comments
- 7121 reads
Chronic cutaneous ulcers: etiology and epidemiology. J Invest Dermatol. 1994;102:38S–41S.
3. Abbade LP, Lastoria S, De Almeida Rollo H, et al. A sociodemographic,clinical study of patients with venous ulcer. Int J Dermatol. 2005;44:989–992.
4. Callam MJ, Ruckley CV, Harper DR,Dale JJ. Chronic ulceration of the leg: extent of the problem and provision of care. Br Med J (Clin Res Ed). 1985;290:1855–1856.
5. Morrell CJ, Walters SJ, Dixon S, et al. Cost effectiveness of community leg ulcer clinics: randomized controlled trial. BMJ. 1998;316(7143):1487–1491.
6. Trent JT, Falabella A, Eaglstein WH, et al. Venous ulcers: pathophysiology and treatment options. Ostomy Wound Manage. 2005;51(5):38–54.
7. Bianco P, Riminucci M, Gronthos S, Satomura K, Bianco P, Robey PG. Circulating skeletal stem cells: nature biology and potential applications. Stem Cells. 2001;19(3):180–192.
8. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418(6893):31–49.
9. Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 2001;105(3):369–377.
10. Pittenger MF, Mackay AM, Beck SC, et al. Multi-lineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–147.
11. Schuldiner M, Yanuka O, Itskovitz-Eldor J, Melton DA, Benvenisty N. Effects of eight growth factors on the differentiation of cells derived from human
embryonic stem cells. Proc Natl Acad Sci U S A. 2000;97(21):11307–11312.
12. Watt FM, Hogan BL. Out of Eden: stem cells and their niches. Science. 2000;287(5457):1427–1430.
13. Stanley A, Osler T. Senescence and the healing rates of venous ulcers. J Vasc Surg. 2001;33(6):1206–1211.
14. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276(5309):71–74.
15. Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol. 2001;69(4):513–521.
16. Lingen MW. Role of leukocytes and endothelial cells in the development of angiogenesis in inflammation and wound healing. Arch Pathol Lab Med. 2001;125(1):67–71.
17. Mendez MV, Stanley A, Phillips T, Murphy M, Menzoian JO, Park HY. Fibroblasts cultured from distal lower extremities in patients with venous reflux display cellular characteristics of senescence. J Vasc Surg. 1998;28(6);1040–1050.
18. Raffetto JD, Mendez MV, Phillips TJ, Park HY, Menzoian JO. The effect of passage number on fibroblast cellular senescence in patients with chronic venous insufficiency with and without ulcer. Am J Surg. 1999;178(2):107–112.
19. Vande Berg JS, Rudolf R, Holland C, Haywood-Reid PL. Fibroblast senescence in pressure ulcers. Wound Repair Regen. 1998;6(1):38–49.
20. McFarlin K, Gao X, Liu YB, et al. Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat. Wound Repair Regen. 2006;14(4):471–478.
21. Deng W, Han Q, Liao L, et al. Engrafted bone marrow-derived flk-(1þ) mesenchymal stem cells regenerate skin tissue. Tissue Eng. 2005;11(1-2):110–119.
22. Rogers LC, Bevilacqua NJ, Armstrong DG. The use of marrow-derived stem cells to accelerate healing in chronic wounds. Int Wound J. 2008;5(1):20–25.
23. Badiavas EV, Falanga V. Treatment of chronic wounds
with bone marrow-derived cells. Arch Dermatol. 2003;139(4):510–516.
24. Badiavas EV, Ford D, Liu P, et al. Long-term bone marrow culture and its clinical potential in chronic wound healing. Wound Repair Regen. 2007;15(6):856–865.
25. Yoshikawa T, Mitsuno H, Nonaka I, et al. Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg. 2008;121(3):860–877.
26. Falanga V, Iwamoto S, Chartier M, et al.